Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomisation analysisNaomi Cornish, Philip Haycock, Hermann Brenner, et al.
Transplantation|November 12, 2024
Comparative Outcome Analysis of Lenvatinib Versus Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver TransplantationChristian T J Magyar, Sheron Perera, Luckshi Rajendran, et al.
Frontiers in Immunology|January 7, 2025
Association between somatic microsatellite instability, hypermutation status, and specific T cell subsets in colorectal cancer tumorsClaire E Thomas, Yasutoshi Takashima, Evertine Wesselink, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2025
Density of T cell subsets in colorectal cancer in relation to disease-specific survivalClaire E Thomas, Yasutoshi Takashima, Daniel D Buchanan, et al.
Current Oncology (Toronto, Ont.)|June 26, 2024
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in CanadaQi Guan, Suriya J Aktar, Reka E Pataky, et al.
Journal of Clinical Pathology|September 29, 2021
Molecular characterisation of pancreatic ductal adenocarcinoma with <i>NTRK</i> fusions and review of the literatureMichael J Allen, Amy Zhang, Prashant Bavi, et al.
International Journal of Epidemiology|December 21, 2023
Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysisNaomi Cornish, Philip Haycock, Hermann Brenner, et al.
Gastroenterology|October 28, 2017
Exome-Wide Association Study of Pancreatic Cancer RiskRobert C Grant, Robert E Denroche, Ayelet Borgida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal AdenocarcinomaSheron Perera, Gun Ho Jang, Yifan Wang, et al.
Pageof 9